41.51
-0.03(-0.07%)
Currency In USD
| Previous Close | 41.54 |
| Open | 41.75 |
| Day High | 41.76 |
| Day Low | 39.43 |
| 52-Week High | 90.32 |
| 52-Week Low | 39.43 |
| Volume | 1.89M |
| Average Volume | 1.81M |
| Market Cap | 2.23B |
| PE | -23.72 |
| EPS | -1.75 |
| Moving Average 50 Days | 49.39 |
| Moving Average 200 Days | 67.09 |
| Change | -0.03 |
If you invested $1000 in Soleno Therapeutics, Inc. (SLNO) 10 years ago, it would be worth $84.5 as of January 14, 2026 at a share price of $41.51. Whereas If you bought $1000 worth of Soleno Therapeutics, Inc. (SLNO) shares 5 years ago, it would be worth $253.88 as of January 14, 2026 at a share price of $41.51.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results
GlobeNewswire Inc.
Jan 12, 2026 12:00 PM GMT
REDWOOD CITY, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced select preliminary financial an
Soleno Therapeutics Announces Publication of Results from Pivotal Study of VYKAT™ XR in the Journal of Clinical Endocrinology and Metabolism
GlobeNewswire Inc.
Jan 05, 2026 1:00 PM GMT
REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced a publication in the peer-revie
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
GlobeNewswire Inc.
Dec 03, 2025 9:05 PM GMT
REDWOOD CITY, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today regrets to announce the passing of Willia